These data revealed a potential association between HSPA2 overexpression and malignant phenotypes, such as metastasis, consistent with other reports in breast cancer[7], cervical cancer[8] and bladder urothelial carcinoma[9]. The gene discussed is HSPA2; the disease is breast carcinoma.